Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer.

Journal of translational medicine

Volumn 10 Suppl 1, Issue , 2012, Pages

  Tang, Yiqing ^a   Zhu, L ^b   Li, Yafen ^b   Ji, Jun ^b   Li, Jianfang ^b   Yuan, Fei ^b   Wang, Dengbin ^b   Chen, Weiguo ^b   Huang, O ^b   Chen, Xiaosong ^b   Wu, Jiayi ^b   Shen, Kunwei ^b   Loo, Wings T Y ^b   Chow, Louis W C ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM, RESIDUAL; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TREATMENT OUTCOME;

EID: 84877683942     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-s1-s4     Document Type: Article

References (0)